User Beware: We Need More Science and Less Art When Measuring Financial Toxicity in Oncology

被引：16

作者：

de Souza, Jonas A. ^{[1
]}

Yap, Bonnie ^{[1
]}

Ratain, Mark J. ^{[1
]}

Daugherty, Christopher ^{[1
]}

机构：

[1] Univ Chicago, Chicago, IL 60637 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 12期

关键词：

CANCER;

D O I：

10.1200/JCO.2014.59.4986

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1414 / +

页数：3

共 8 条

[1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].

AARONSON, NK ;

AHMEDZAI, S ;

BERGMAN, B ;

BULLINGER, M ;

CULL, A ;

DUEZ, NJ ;

FILIBERTI, A ;

FLECHTNER, H ;

FLEISHMAN, SB ;

DEHAES, JCJM ;

KAASA, S ;

KLEE, M ;

OSOBA, D ;

RAZAVI, D ;

ROFE, PB ;

SCHRAUB, S ;

SNEEUW, K ;

SULLIVAN, M ;

TAKEDA, F .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376

[2]

Camber R., 2008, DAILY MAIL

[3] The Development of a Financial Toxicity Patient-Reported Outcome in Cancer The COST Measure [J].

de Souza, Jonas A. ;

Yap, Bonnie J. ;

Hlubocky, Fay J. ;

Wroblewski, Kristen ;

Ratain, Mark J. ;

Cella, David ;

Daugherty, Christopher K. .

CANCER, 2014, 120 (20) :3245-3253

[4] Reporting and Grading Financial Toxicity [J].

Khera, Nandita .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (29) :3337-+

[5] Content Validity-Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2-Assessing Respondent Understanding [J].

Patrick, Donald L. ;

Burke, Laurie B. ;

Gwaltney, Chad J. ;

Leidy, Nancy Kline ;

Martin, Mona L. ;

Molsen, Elizabeth ;

Ring, Lena .

VALUE IN HEALTH, 2011, 14 (08) :978-988

[6]

Prawitz A.D., 2006, J FINANC COUNS PLAN, V17, P34

[7]

Ratain MJ., 2009, AAAS FDLI C PERS MED

[8]

Selden TM, 2003, MED CARE, V41, P13

← 1 →